ARTICLE | Clinical News

Carbavance: Phase III started

November 17, 2014 8:00 AM UTC

The Medicines Co. began the open-label U.S. Phase III TANGO 2 trial to compare thrice-daily 2 g/2 g IV Carbavance vs. the best available therapy with IV antibiotics for 14 days in about 150 adults with serious gram-negative bacterial infections. ...